Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
3,776.46
4,213.14
3,490.93
3,069.41
3,043.86
2,806.13
3,084.96
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,776.46
4,213.14
3,490.93
3,069.41
3,043.86
2,806.13
3,084.96
Raw Material Cost
1,652.03
1,958.51
1,455.31
1,304.48
1,400.19
1,180.43
1,300.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
86.01
93.12
101.79
117.12
71.59
59.37
21.45
Selling and Distribution Expenses
2,000.16
2,592.77
1,784.60
1,505.26
1,400.59
1,154.48
1,099.55
Other Expenses
-6.29
-5.11
-7.94
-8.67
-3.46
-3.46
0.94
Total Expenditure (Excl Depreciation)
3,675.29
4,593.32
3,262.32
2,840.17
2,837.78
2,359.70
2,430.57
Operating Profit (PBDIT) excl Other Income
101.19999999999999
-380.20000000000005
228.6
229.20000000000002
206.1
446.4
654.4
Other Income
61.59
26.23
56.42
-11.00
67.78
42.68
17.53
Operating Profit (PBDIT)
240.12
-267.17
382.91
323.18
381.36
578.72
757.53
Interest
86.01
93.12
101.79
117.12
71.59
59.37
21.45
Exceptional Items
75.29
6.69
15.06
61.36
31.34
25.54
0.33
Gross Profit (PBDT)
2,124.43
2,254.63
2,035.62
1,764.93
1,643.67
1,625.69
1,784.79
Depreciation
124.96
124.24
123.49
113.78
117.04
97.84
85.61
Profit Before Tax
104.45
-477.84
172.69
153.64
224.07
447.06
650.80
Tax
30.14
-80.61
22.81
32.10
55.04
71.20
94.06
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
33.62
-414.51
138.47
118.48
152.38
282.75
563.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
33.62
-414.51
138.47
118.48
152.38
282.75
563.24
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.14
2.05
-2.23
-8.95
1.35
1.80
8.53
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
36.77
-412.46
136.25
109.53
153.73
284.55
571.77
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
0.0
0.0
0.0
Reserves
3,181.17
3,512.36
3,993.77
3,874.86
3,893.86
4,051.91
3,870.15
Earnings per share (EPS)
0.02
-0.3
0.1
0.08
0.11
0.2
0.4
Diluted Earnings per share
0.02
-0.3
0.1
0.08
0.11
0.2
0.4
Operating Profit Margin (Excl OI)
1.42%
-9.91%
5.82%
7.18%
6.46%
15.62%
21.21%
Gross Profit Margin
6.07%
-8.39%
8.48%
8.71%
11.21%
19.42%
23.87%
PAT Margin
0.89%
-9.84%
3.97%
3.86%
5.01%
10.08%
18.26%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -10.36% vs 20.69% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 108.92% vs -402.86% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 160.84% vs -189.86% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -7.63% vs -8.55% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Guizhou Bailing Group Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
3,776.46
0
3,776.46
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,776.46
0
3,776.46
Raw Material Cost
1,652.03
0
1,652.03
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
86.01
0
86.01
Selling and Distribution Expenses
2,000.16
0
2,000.16
Other Expenses
-6.29
0.00
-6.29
Total Expenditure (Excl Depreciation)
3,675.29
0
3,675.29
Operating Profit (PBDIT) excl Other Income
101.18
0.00
101.18
Other Income
61.59
0
61.59
Operating Profit (PBDIT)
240.12
0
240.12
Interest
86.01
0
86.01
Exceptional Items
75.29
0
75.29
Gross Profit (PBDT)
2,124.43
0
2,124.43
Depreciation
124.96
0
124.96
Profit Before Tax
104.45
0
104.45
Tax
30.14
0
30.14
Provisions and contingencies
0
0
0.00
Profit After Tax
33.62
0
33.62
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
33.62
0
33.62
Share in Profit of Associates
0
0
0.00
Minority Interest
3.14
0
3.14
Other related items
0.00
0.00
0.00
Consolidated Net Profit
36.77
0
36.77
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,181.17
0
3,181.17
Earnings per share (EPS)
0.02
0
0.02
Diluted Earnings per share
0.02
0
0.02
Operating Profit Margin (Excl OI)
1.42%
0%
0.00
1.42%
Gross Profit Margin
6.07%
0%
0.00
6.07%
PAT Margin
0.89%
0%
0.00
0.89%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 377.65 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -10.36% vs 20.69% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 3.68 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 108.92% vs -402.86% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.85 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 160.84% vs -189.86% in Dec 2023
Annual - Interest
Interest 8.60 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -7.63% vs -8.55% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.42%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






